These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35403239)

  • 1. Bayesian sample size determination for diagnostic accuracy studies.
    Wilson KJ; Williamson SF; Allen AJ; Williams CJ; Hellyer TP; Lendrem BC
    Stat Med; 2022 Jul; 41(15):2908-2922. PubMed ID: 35403239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian consensus-based sample size criteria for binomial proportions.
    Joseph L; Bélisle P
    Stat Med; 2019 Oct; 38(23):4566-4573. PubMed ID: 31297825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian and mixed Bayesian/likelihood criteria for sample size determination.
    Joseph L; du Berger R; Bélisle P
    Stat Med; 1997 Apr; 16(7):769-81. PubMed ID: 9131764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay.
    Vradi E; Jaki T; Vonk R; Brannath W
    Stat Methods Med Res; 2019 Aug; 28(8):2538-2556. PubMed ID: 29966502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic approach for dynamically incorporating predicate device data in prospective diagnostic test studies.
    Hickey GL; Parvu V; Zhang Y; Cooper CK; Wan Y
    J Biopharm Stat; 2023 Jan; 33(1):77-89. PubMed ID: 35649152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A general framework for comparative Bayesian meta-analysis of diagnostic studies.
    Menten J; Lesaffre E
    BMC Med Res Methodol; 2015 Aug; 15():70. PubMed ID: 26315894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian sample-size determination for inference on two binomial populations with no gold standard classifier.
    Stamey JD; Seaman JW; Young DM
    Stat Med; 2005 Oct; 24(19):2963-76. PubMed ID: 16007574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian and influence function-based empirical likelihoods for inference of sensitivity to the early diseased stage in diagnostic tests.
    Hai Y; Shi S; Qin G; For The Alzheimer's Disease Neuroimaging
    Biom J; 2023 Mar; 65(3):e2200021. PubMed ID: 36642803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote, real-time expert elicitation to determine the prior probability distribution for Bayesian sample size determination in international randomised controlled trials: Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone (BIPED) study.
    Lan J; Plint AC; Dalziel SR; Klassen TP; Offringa M; Heath A;
    Trials; 2022 Apr; 23(1):279. PubMed ID: 35410375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size estimation in diagnostic test studies of biomedical informatics.
    Hajian-Tilaki K
    J Biomed Inform; 2014 Apr; 48():193-204. PubMed ID: 24582925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test.
    Dendukuri N; Rahme E; Bélisle P; Joseph L
    Biometrics; 2004 Jun; 60(2):388-97. PubMed ID: 15180664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflict.
    Calderazzo S; Wiesenfarth M; Kopp-Schneider A
    Biostatistics; 2022 Jan; 23(1):328-344. PubMed ID: 32735010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian sample size determination for phase IIA clinical trials using historical data and semi-parametric prior's elicitation.
    Berchialla P; Zohar S; Baldi I
    Pharm Stat; 2019 Mar; 18(2):198-211. PubMed ID: 30440109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Two Bayesian Methods in Evaluation of the Absence of the Gold Standard Diagnostic Tests.
    Li T; Liu P
    Biomed Res Int; 2019; 2019():1374748. PubMed ID: 31531344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction to Bayes' theorem and examples of its application to a diagnostic test and a clinical trial.
    Thi Mai H; He S; Alexandrou E; Alfred Frost S
    Nurse Res; 2022 Mar; 30(1):39-43. PubMed ID: 35174675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian and influence function-based empirical likelihoods for inference of sensitivity in diagnostic tests.
    Hai Y; Min X; Qin G;
    Stat Methods Med Res; 2020 Dec; 29(12):3457-3491. PubMed ID: 32552342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.
    Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2007; 17(1):93-108. PubMed ID: 17219757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.